ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0470

Educational Intervention to Increase Contraception Screening and Documentation for Reproductive-Aged Women Seen in an Academic Rheumatology Clinic

Caroline Siegel1, Deanna Jannat-Khah1, Avi Mikhaylov1, Erika Abramson2, Nancy Pan1 and Lisa Sammaritano3, 1Hospital for Special Surgery, New York, NY, 2Weill Cornell Medicine, New York, NY, 3Hospital for Special Surgery, Weill Cornell Medicine, New York, NY

Meeting: ACR Convergence 2023

Keywords: Intervention, quality of care, Women's health

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: (0460–0479) Reproductive Issues in Rheumatic Disorders Poster I

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Only one-third of reproductive-aged women with rheumatic disease (RD) are prescribed effective contraception, even if prescribed teratogenic medications (Talabi et al. Arthritis Care Res. 2019). Contraception counseling and documentation are important steps to improve effective contraception use in at-risk patients; however, in a nationwide study, less than 10% of women with SLE or RA had contraception documented in a structured electronic health record (EHR) field (Clowse et al. Arthritis Care Res. 2023). The aim of this quality improvement (QI) initiative was to increase the rate of provider screening and documentation of contraception use for female patients aged 18-45 seen in an academic rheumatology clinic from our baseline of 11% to 50% by 24 weeks.

Methods: We administered a survey to clinic staff including demographic information, professional credentials and years of experience, and barriers to contraception documentation and desired interventions. We conducted 6 Plan-Do-Study-Act (PDSA) cycles including educational presentations and motivating reminders for clinic staff, devised to address the “vital few” barriers (representing 80% of responses) identified.

The primary outcome measure was the percentage of the study population with contraception use documented in the structured EHR field. The primary balancing measure was the percentage of the study population with smoking status documented in the structured EHR field. The primary process measure was percentage of contraception documenters who were non-MD clinical staff, as the intervention focused on this group. We tracked primary outcome, process, and balancing measures at 2-week intervals over 24 weeks; we tracked primary outcome and balancing measures on a run chart.

Results: Baseline survey respondents (n=17) were 65% female; 47% White and 29% Asian/Indian; 82% Not Hispanic/Latino; 53% Registered Nurses/Personal Care Assistants and 47% Rheumatology Fellows [Table]. The “vital few” barriers to contraception documentation were not having been told to document this information and lack of awareness of this EHR field [Fig. 1]. The intervention most frequently suggested by respondents (47%) was education.

Interventions included an introductory educational session with documentation instruction and scripts to guide screening (PDSA #1), email reminders from nursing leadership (PDSA #2 and #5), and interim educational sessions (PDSA #3, #4, #6). Over 24 weeks, the rate of contraception documentation increased from 11% to 54% (median 30%) and the median smoking status documentation rate was 88% (68%-97% range) [Fig. 2]; the median rate of non-MD clinical staff documenters was 92% (70%-100% range).

Conclusion: A multi-cycle educational intervention designed based on key stakeholder feedback led to an increase in the contraception documentation rate from 11% to 54% for reproductive-aged women seen in our rheumatology clinic over 24 weeks. Future phases of this QI initiative will focus on encouraging rheumatologists to provide contraceptive counseling and referrals to women’s health providers for patients who are prescribed teratogenic medications.

Supporting image 1

Supporting image 2

Supporting image 3


Disclosures: C. Siegel: UCB, 12, fellowship training is supported by UCB Women's Health Fellowship Program; D. Jannat-Khah: AstraZeneca, 12, stock ownership, Cytodyn, 12, stock ownershil[, Walgreens Boots Alliance, 12, stock ownership; A. Mikhaylov: None; E. Abramson: None; N. Pan: None; L. Sammaritano: None.

To cite this abstract in AMA style:

Siegel C, Jannat-Khah D, Mikhaylov A, Abramson E, Pan N, Sammaritano L. Educational Intervention to Increase Contraception Screening and Documentation for Reproductive-Aged Women Seen in an Academic Rheumatology Clinic [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/educational-intervention-to-increase-contraception-screening-and-documentation-for-reproductive-aged-women-seen-in-an-academic-rheumatology-clinic/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/educational-intervention-to-increase-contraception-screening-and-documentation-for-reproductive-aged-women-seen-in-an-academic-rheumatology-clinic/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology